Skip to content
Screener

Charles River Laboratories CRL Prepaid & Other Current

Prepaid & Other Current at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$23.1M-96.5%
Rapid Micro Biosystems logo
Rapid Micro BiosystemsRPID
$2.06M-9.6%
Sotera Health logo
Sotera HealthSHC
$74.74M+13.2%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$17.36M-33.8%
Fortrea Holdings Inc. logo
Fortrea Holdings Inc.FTRE
$100.6M-27.9%
Revvity logo
RevvityRVTY
$189.11M+4.1%

Other financials

Income statement

See full
Revenue$1.0B-2.7%
Gross profit$349.0M-3.5%
Operating income$119.9M+19.7%
Net income-$1.5M-103%
EPS (diluted)-$0.03-103%

Balance sheet

See full
Cash & equivalents$240.6M+30.2%
Total debt$3.0B+8.1%
Total equity$2.8B-15.3%
Total assets$7.5B-0.4%

Cash flow

See full
Operating cash flow$179.7M-12.2%
CapEx$31.1M-11.9%
Free cash flow$148.6M-12.2%

Valuation

See full
Market cap$12.56B+70.1%
Enterprise value$15.36B+53.4%
P/S3.1×+1.3×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-6%
FCF margin9.3%-5.1pp

Returns & leverage

See full
Return on equity-7.7%
Debt / equity1.1×+0.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 9:21 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001100682-26-000118
Line itemJune 27, 2026December 27, 2025
Trade receivables and contract assets, net of allowances for credit losses of $8,715 and $10,463, respectively711,755708,856
Inventories346,260299,103
Prepaid assets100,40996,108
Other current assets178,657129,212
Total current assets1,529,1061,447,049
Property, plant and equipment, net1,494,9141,655,219
Venture capital and strategic equity investments206,470206,972
Operating lease right-of-use assets, net330,247361,415

Item 1. Financial Statements

FAQ

What is Charles River Laboratories's prepaid & other current?
Charles River Laboratories (CRL) reported prepaid & other current of $178.66M in Q2 2026.
How has Charles River Laboratories's prepaid & other current changed year-over-year?
Charles River Laboratories's prepaid & other current increased by 37.5% year-over-year, from $129.92M to $178.66M.
What is the long-term trend for Charles River Laboratories's prepaid & other current?
Over 5 years (2020 to 2025), Charles River Laboratories's prepaid & other current has grown at a 12.2% compound annual growth rate (CAGR), from $72.56M to $129.21M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about Charles River Laboratories's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude